Molly McElwee Malloy was my first interview here. She’s also my latest interview here.
A little over two months after the birth of Happy Medium, I saw Molly give a speech at a local JDRF meeting in Baltimore. At the time, she was clinical research coordinator at the Center for Diabetes Technology at the University of Virginia. She is also an RN and a Certified Diabetes Educator, and has been living with Type 1 Diabetes since 1998.
That was the first time I had seen anyone speak live about artificial pancreas development, how everything worked, and actually show me photos of the device they were testing. I was jazzed up about it, and the next day (and the day after that), I really bothered Molly for an interview. She said no, but said she would answer any questions I might have, so I could get all my facts straight.
In that instance as a new diabetes blogger with two months experience, and in the three years since, she has been kind, patient, and gracious when bombarded by my enthusiasm and my never-ending list of questions.
This month, Molly stepped into her latest role as Head of Patient Engagement at Type Zero Technologies, which is the commercial arm of AP research that was born many years ago at UVA’s Center for Diabetes Technology.
I am proud to say that she has finally gone on the record with me, for about 13 minutes, to talk about Type Zero and their InControl platform, including InControl Advice and InControl Cloud. She talks about those three products, the timing of upcoming clinical trials, and the plan for submitting these for approval to the U.S. Food and Drug Administration.
In reality, I wish we had more time, because this discussion could have easily gone two or three episodes. Instead, you’ll have to be satisfied with this little teaser, and then go to the Type Zero website to learn more.
Also, and this is important: Clinical trial participants are a very important piece of cutting-edge development like this. Please see below to find out more about volunteering to participate.
Reference Material – Click below for more information on this topic
Find out more by going to the Type Zero Technologies website:
Follow Molly McElwee Malloy on Twitter:
Clinical trial participants are necessary and appreciated! Interested? Send an e-mail to: